Literature DB >> 14672892

Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

M Lopez-Hoyos1, M J Bartolome-Pacheco, R Blanco, V Rodriguez-Valverde, V M Martinez-Taboada.   

Abstract

OBJECTIVES: To investigate the phenotype and T cell receptor (TCR) use in peripheral blood T cells in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
METHODS: Circulating T lymphocyte phenotype and TCR repertoire were studied by flow cytometry using specific monoclonal antibodies in 23 healthy controls and 37 patients with PMR/GCA.
RESULTS: Patients with active PMR/GCA showed an inverse relation between naive and memory CD4+ T cells and unchanged expression of activation surface markers compared with controls. CD4+ TCR BV expansions were seen in 12 (52%) controls and in 8 (22%) patients with active disease (p = 0.03). Within the CD8+ subset, the frequency of expansions was similar between groups. Most T cell expansions remained stable over time. Seventeen of the 23 patients with active PMR/GCA disclosed a simultaneous CD4+ and CD8+ T cell depletion for at least one particular BV family with a clear predominance of BV5S2/S3.
CONCLUSIONS: The phenotype of circulating T cells in patients with PMR/GCA is similar to that found in aged healthy subjects, except for the surface markers of naive and memory cells and a striking non-activated phenotype. Specific BV expansions in CD4+ and CD8+ T cells, which remain stable over time, are frequent in aged subjects, including patients with PMR/GCA. TCR BV changes in patients with active disease seem to be also age related, except for the significant decrease in certain BV families in both CD4+ and CD8+ T cell subsets, which may favour the participation of a superantigen stimulation in PMR/GCA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14672892      PMCID: PMC1754713          DOI: 10.1136/ard.2003.005900

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  48 in total

Review 1.  Giant cell arteritis.

Authors:  Stuart M Levine; David B Hellmann
Journal:  Curr Opin Rheumatol       Date:  2002-01       Impact factor: 5.006

2.  Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis.

Authors:  L Ginaldi; M De Martinis; A D'Ostilio; L Marini; F Loreto; M Modesti; D Quaglino
Journal:  Am J Hematol       Date:  2001-06       Impact factor: 10.047

Review 3.  Interplay between superantigens and the immune system.

Authors:  M J Irwin; N R Gascoigne
Journal:  J Leukoc Biol       Date:  1993-11       Impact factor: 4.962

4.  The Crohn's disease-associated bacterial protein I2 is a novel enteric t cell superantigen.

Authors:  H Dalwadi; B Wei; M Kronenberg; C L Sutton; J Braun
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

Review 5.  Clinical relevance of age-related immune dysfunction.

Authors:  S C Castle
Journal:  Clin Infect Dis       Date:  2000-09-14       Impact factor: 9.079

Review 6.  Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.

Authors:  V M Martinez-Taboada; R Blanco; C Fito; M J Pacheco; M Delgado-Rodriguez; V Rodriguez-Valverde
Journal:  Semin Arthritis Rheum       Date:  2001-02       Impact factor: 5.532

7.  Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes.

Authors:  P Duhaut; S Bosshard; A Calvet; L Pinede; S Demolombe-Rague; C Dumontet; R Loire; D Seydoux; J Ninet; J Pasquier; M Aymard
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

8.  Oligoclonality in the human CD8+ T cell repertoire in normal subjects and monozygotic twins: implications for studies of infectious and autoimmune diseases.

Authors:  J Monteiro; R Hingorani; I H Choi; J Silver; R Pergolizzi; P K Gregersen
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

9.  TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients.

Authors:  D Navaneetham; A S Penn; J F Howard; B M Conti-Fine
Journal:  J Autoimmun       Date:  1998-12       Impact factor: 7.094

10.  Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes.

Authors:  P Duhaut; L Pinede; S Demolombe-Rague; R Loire; D Seydoux; J Ninet; J Pasquier
Journal:  Arthritis Rheum       Date:  1998-11
View more
  4 in total

1.  An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.

Authors:  C Schaufelberger; R Andersson; E Nordborg; G K Hansson; C Nordborg; J Wahlström
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

2.  T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation.

Authors:  William Vernau; Brian J Hartnett; Douglas R Kennedy; Peter F Moore; Paula S Henthorn; Kenneth I Weinberg; Peter J Felsburg
Journal:  Biol Blood Marrow Transplant       Date:  2007-08-02       Impact factor: 5.742

Review 3.  Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 4.  CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors?

Authors:  Rosanne D Reitsema; Annemieke M H Boots; Kornelis S M van der Geest; Maria Sandovici; Peter Heeringa; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.